Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
AstraZeneca
Dow
Moodys
Boehringer Ingelheim

Last Updated: August 15, 2022

Mechanism of Action: Norepinephrine Uptake Inhibitors


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Drugs with Mechanism of Action: Norepinephrine Uptake Inhibitors

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Inc VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET;ORAL 078627-003 Jun 13, 2008 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Nostrum Labs Inc VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 205468-003 Mar 24, 2017 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Inventia Hlthcare VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 203332-002 Mar 12, 2020 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Dr Reddys Labs Ltd VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 078421-001 May 6, 2011 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Teva VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET;ORAL 076690-005 Aug 3, 2006 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Torrent VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 090899-001 Jun 1, 2011 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Mallinckrodt
Baxter
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.